
GRML vs IMA
$GRML vs $IMA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GRML vs IMA: the quick read
- ·IMA is the larger company by market cap ($48M vs $42M).
- ·GRML has been more active on our scanner (572 vs 0 alerts in 30 days).
- ·GRML has the smaller float (7.6M vs 9.8M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·Only one of them shows up on our scanner: GRML triggered 572 unusual-volume alerts in the last 30 days and the other triggered none.
- ·They are closely matched in size, within 14% of each other on market cap, which makes the rest of this table the interesting part.
- ·They are pulling apart today: GRML is outperforming the other by roughly 11.3 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GRML and IMA on TheDesperateTrader.
- Is GRML or IMA the better stock?
- "Better" depends on your goal, and these two are not alike. IMA is the larger company by market cap ($48M vs $42M). GRML has been more active on our scanner (572 vs 0 alerts in 30 days). GRML has the smaller float (7.6M vs 9.8M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GRML and IMA?
- The differences that matter: they are not in the same business - GRML is biological products, (no diagnostic substances) and IMA is biological products, (no diagnostic substances); they are similar in size ($42M vs $48M); they trade at very different share prices ($6.05 vs $4.15); GRML sits at 33% of its 52-week range against 5% for IMA; our scanner flagged GRML 572 times in the last 30 days against 0 for IMA. Everything above is measured from the latest completed session and SEC filings.
- Which of GRML and IMA is more active right now?
- Right now GRML is at about 0.1x its normal volume and IMA is at about 0.6x, so IMA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GRML or IMA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GRML and IMA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.